Gene Symbol | Gene ID | Gene Info |
---|---|---|
POU5F1
|
ENSG00000204531.11 | POU class 5 homeobox 1 |
POU2F3
|
ENSG00000137709.5 | POU class 2 homeobox 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_120110982_120111133 | POU2F3 | 154 | 0.951324 | -0.50 | 1.7e-01 | Click! |
chr11_120095962_120096113 | POU2F3 | 11312 | 0.160189 | -0.44 | 2.4e-01 | Click! |
chr11_120119674_120119825 | POU2F3 | 8846 | 0.171166 | 0.43 | 2.5e-01 | Click! |
chr11_120094706_120094857 | POU2F3 | 12568 | 0.157293 | -0.34 | 3.7e-01 | Click! |
chr11_120095512_120095663 | POU2F3 | 11762 | 0.159136 | -0.18 | 6.5e-01 | Click! |
chr6_31147991_31148192 | POU5F1 | 417 | 0.674033 | -0.25 | 5.1e-01 | Click! |
chr6_31148269_31148530 | POU5F1 | 109 | 0.920496 | -0.16 | 6.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_197825673_197826397 | 1.58 |
AC073135.3 |
|
11042 |
0.16 |
chr3_197831468_197832400 | 1.43 |
AC073135.3 |
|
5143 |
0.19 |
chr12_117420918_117421075 | 1.29 |
RP11-231I16.1 |
|
4146 |
0.28 |
chr11_118305386_118306890 | 1.17 |
RP11-770J1.4 |
|
217 |
0.83 |
chr21_28214648_28215240 | 1.15 |
ADAMTS1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
393 |
0.9 |
chr11_126869922_126870139 | 1.02 |
KIRREL3 |
kin of IRRE like 3 (Drosophila) |
386 |
0.81 |
chr2_216299376_216299642 | 0.97 |
FN1 |
fibronectin 1 |
1281 |
0.4 |
chr6_161860389_161860563 | 0.95 |
AGPAT4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
165383 |
0.04 |
chr12_54611665_54611918 | 0.93 |
ENSG00000265371 |
. |
13469 |
0.1 |
chr22_46423027_46423794 | 0.91 |
RP6-109B7.5 |
|
25563 |
0.09 |
chr5_126626527_126627025 | 0.90 |
MEGF10 |
multiple EGF-like-domains 10 |
225 |
0.95 |
chr13_30027327_30027478 | 0.89 |
MTUS2 |
microtubule associated tumor suppressor candidate 2 |
24556 |
0.22 |
chr3_190391964_190392141 | 0.88 |
ENSG00000223117 |
. |
32100 |
0.21 |
chr5_134825154_134825603 | 0.88 |
TIFAB |
TRAF-interacting protein with forkhead-associated domain, family member B |
37289 |
0.11 |
chr7_19154676_19154916 | 0.87 |
TWIST1 |
twist family bHLH transcription factor 1 |
2499 |
0.21 |
chr4_71997150_71997347 | 0.87 |
SLC4A4 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
55755 |
0.16 |
chr5_121409447_121409998 | 0.86 |
LOX |
lysyl oxidase |
4258 |
0.27 |
chrX_69674453_69675874 | 0.85 |
DLG3 |
discs, large homolog 3 (Drosophila) |
217 |
0.75 |
chr1_33358402_33358643 | 0.85 |
HPCA |
hippocalcin |
6486 |
0.13 |
chrX_128656025_128656195 | 0.84 |
SMARCA1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
1350 |
0.49 |
chr8_49832237_49832502 | 0.83 |
SNAI2 |
snail family zinc finger 2 |
1619 |
0.54 |
chr4_177244788_177244939 | 0.83 |
RP11-87F15.2 |
|
3254 |
0.25 |
chr7_100464814_100466140 | 0.82 |
TRIP6 |
thyroid hormone receptor interactor 6 |
717 |
0.47 |
chr19_30719241_30719606 | 0.82 |
ZNF536 |
zinc finger protein 536 |
2 |
0.73 |
chr15_23931247_23932124 | 0.82 |
NDN |
necdin, melanoma antigen (MAGE) family member |
765 |
0.7 |
chrX_10587548_10588615 | 0.82 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
378 |
0.91 |
chr19_29492860_29493011 | 0.80 |
ENSG00000252272 |
. |
358 |
0.93 |
chr4_113739356_113739869 | 0.79 |
ANK2 |
ankyrin 2, neuronal |
347 |
0.9 |
chr14_27065895_27066046 | 0.78 |
NOVA1 |
neuro-oncological ventral antigen 1 |
318 |
0.85 |
chr11_57545200_57545645 | 0.77 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
3653 |
0.19 |
chr13_65834890_65835427 | 0.77 |
ENSG00000221685 |
. |
603147 |
0.0 |
chr8_42063953_42065062 | 0.77 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr5_111091378_111091829 | 0.76 |
NREP |
neuronal regeneration related protein |
345 |
0.9 |
chrX_34673071_34673254 | 0.76 |
TMEM47 |
transmembrane protein 47 |
2243 |
0.48 |
chr12_52400775_52401965 | 0.76 |
GRASP |
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein |
646 |
0.62 |
chr6_16200733_16201077 | 0.76 |
ENSG00000251831 |
. |
4340 |
0.21 |
chr11_64126691_64127568 | 0.74 |
RPS6KA4 |
ribosomal protein S6 kinase, 90kDa, polypeptide 4 |
373 |
0.73 |
chr3_16219029_16219297 | 0.74 |
GALNT15 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
2947 |
0.33 |
chr4_17060566_17060738 | 0.74 |
LDB2 |
LIM domain binding 2 |
160220 |
0.04 |
chr9_128521797_128522422 | 0.74 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
11631 |
0.27 |
chr8_77599524_77599676 | 0.72 |
ZFHX4 |
zinc finger homeobox 4 |
3584 |
0.28 |
chr3_197828693_197828955 | 0.72 |
AC073135.3 |
|
8253 |
0.17 |
chr8_119963118_119963285 | 0.72 |
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
1238 |
0.55 |
chr7_77647061_77647212 | 0.72 |
RP5-1185I7.1 |
|
27399 |
0.25 |
chr6_138862905_138863056 | 0.72 |
NHSL1 |
NHS-like 1 |
3868 |
0.32 |
chr5_125475185_125475336 | 0.72 |
ENSG00000265637 |
. |
57268 |
0.17 |
chrX_130962862_130963372 | 0.71 |
ENSG00000200587 |
. |
109867 |
0.07 |
chr11_114237431_114237671 | 0.71 |
RP11-64D24.2 |
|
10258 |
0.16 |
chr7_102554933_102555219 | 0.71 |
LRRC17 |
leucine rich repeat containing 17 |
1624 |
0.38 |
chr10_123900999_123901504 | 0.71 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
15022 |
0.26 |
chr6_19691587_19692480 | 0.70 |
ENSG00000200957 |
. |
49273 |
0.18 |
chr2_66670252_66670507 | 0.70 |
MEIS1 |
Meis homeobox 1 |
282 |
0.85 |
chr13_102105579_102105898 | 0.70 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
720 |
0.77 |
chr9_12792360_12792511 | 0.69 |
LURAP1L |
leucine rich adaptor protein 1-like |
17415 |
0.18 |
chr4_81191052_81191243 | 0.69 |
FGF5 |
fibroblast growth factor 5 |
3354 |
0.31 |
chr10_116451084_116451252 | 0.69 |
ABLIM1 |
actin binding LIM protein 1 |
6754 |
0.26 |
chr12_13350846_13351208 | 0.68 |
EMP1 |
epithelial membrane protein 1 |
1307 |
0.55 |
chr1_196622943_196623164 | 0.68 |
CFH |
complement factor H |
1867 |
0.41 |
chr4_128545168_128545319 | 0.68 |
INTU |
inturned planar cell polarity protein |
817 |
0.75 |
chr10_95766689_95766956 | 0.67 |
PLCE1 |
phospholipase C, epsilon 1 |
13076 |
0.21 |
chr7_28111372_28111552 | 0.67 |
JAZF1 |
JAZF zinc finger 1 |
159 |
0.97 |
chr12_72669274_72669551 | 0.66 |
ENSG00000236333 |
. |
725 |
0.69 |
chr10_114741340_114741544 | 0.66 |
RP11-57H14.2 |
|
29808 |
0.19 |
chr9_14098246_14098397 | 0.66 |
NFIB |
nuclear factor I/B |
82470 |
0.11 |
chr16_54970178_54971110 | 0.66 |
IRX5 |
iroquois homeobox 5 |
4660 |
0.36 |
chr12_115340794_115340945 | 0.65 |
ENSG00000252459 |
. |
165360 |
0.04 |
chr7_106787828_106787991 | 0.65 |
CTA-360L10.1 |
|
13731 |
0.2 |
chr20_4129930_4130735 | 0.65 |
SMOX |
spermine oxidase |
750 |
0.71 |
chr5_87952392_87952543 | 0.65 |
ENSG00000245526 |
. |
10290 |
0.21 |
chr3_114136352_114136558 | 0.65 |
ZBTB20-AS1 |
ZBTB20 antisense RNA 1 |
29939 |
0.18 |
chr10_98272514_98273588 | 0.64 |
TLL2 |
tolloid-like 2 |
617 |
0.79 |
chr16_64245174_64245639 | 0.64 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
848175 |
0.0 |
chr11_27276125_27276386 | 0.64 |
RP11-1L12.3 |
|
34595 |
0.21 |
chr15_83239771_83240251 | 0.64 |
CPEB1 |
cytoplasmic polyadenylation element binding protein 1 |
498 |
0.71 |
chr6_151648337_151648657 | 0.64 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
1674 |
0.27 |
chr2_175203994_175204145 | 0.64 |
AC018470.1 |
Uncharacterized protein FLJ46347 |
1918 |
0.29 |
chrX_122319779_122319930 | 0.63 |
GRIA3 |
glutamate receptor, ionotropic, AMPA 3 |
1089 |
0.69 |
chr5_92948054_92948286 | 0.63 |
ENSG00000251725 |
. |
8324 |
0.21 |
chr4_153272766_153273041 | 0.63 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
1220 |
0.52 |
chr3_157053767_157053918 | 0.63 |
ENSG00000243176 |
. |
49893 |
0.16 |
chr6_43214536_43215130 | 0.63 |
TTBK1 |
tau tubulin kinase 1 |
894 |
0.48 |
chr8_20126437_20126669 | 0.63 |
LZTS1 |
leucine zipper, putative tumor suppressor 1 |
13750 |
0.19 |
chr4_183890629_183890780 | 0.62 |
DCTD |
dCMP deaminase |
51615 |
0.15 |
chr3_116582620_116583104 | 0.62 |
ENSG00000265433 |
. |
13648 |
0.25 |
chr13_24154580_24154749 | 0.62 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
1145 |
0.64 |
chr4_54523037_54523201 | 0.62 |
RP11-317M11.1 |
|
2256 |
0.32 |
chr15_96878987_96879612 | 0.61 |
ENSG00000222651 |
. |
2809 |
0.21 |
chr6_100316163_100316348 | 0.61 |
MCHR2-AS1 |
MCHR2 antisense RNA 1 |
125565 |
0.05 |
chr15_42749974_42750162 | 0.61 |
ZNF106 |
zinc finger protein 106 |
314 |
0.87 |
chr12_54591479_54591630 | 0.61 |
SMUG1 |
single-strand-selective monofunctional uracil-DNA glycosylase 1 |
8776 |
0.11 |
chr2_145235800_145235951 | 0.61 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
39240 |
0.18 |
chr17_30658222_30658373 | 0.60 |
C17orf75 |
chromosome 17 open reading frame 75 |
3265 |
0.19 |
chr5_146835005_146835156 | 0.60 |
DPYSL3 |
dihydropyrimidinase-like 3 |
1251 |
0.58 |
chr4_116035249_116035478 | 0.60 |
NDST4 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 |
331 |
0.94 |
chr6_45523951_45524153 | 0.60 |
ENSG00000252738 |
. |
89789 |
0.09 |
chr2_161491867_161492018 | 0.60 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
141637 |
0.05 |
chr21_17444306_17444457 | 0.60 |
ENSG00000252273 |
. |
36552 |
0.23 |
chr1_35914565_35914729 | 0.59 |
KIAA0319L |
KIAA0319-like |
5661 |
0.2 |
chr4_116194347_116194498 | 0.59 |
NDST4 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 |
159390 |
0.04 |
chr14_90126270_90126545 | 0.59 |
ENSG00000252655 |
. |
9160 |
0.16 |
chr8_146204034_146204185 | 0.59 |
RP5-1047A19.4 |
|
14191 |
0.15 |
chr11_78508450_78508601 | 0.58 |
TENM4 |
teneurin transmembrane protein 4 |
7931 |
0.27 |
chr7_63923820_63924465 | 0.58 |
ZNF680 |
zinc finger protein 680 |
99277 |
0.08 |
chr1_14219689_14219912 | 0.58 |
PRDM2 |
PR domain containing 2, with ZNF domain |
121579 |
0.06 |
chr9_91653559_91653931 | 0.58 |
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
3307 |
0.28 |
chr2_198126557_198126708 | 0.58 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
40611 |
0.13 |
chr1_244836322_244836473 | 0.58 |
DESI2 |
desumoylating isopeptidase 2 |
19344 |
0.23 |
chr2_243030793_243031816 | 0.58 |
AC093642.5 |
|
460 |
0.62 |
chr12_115250983_115251152 | 0.58 |
ENSG00000252459 |
. |
75558 |
0.12 |
chr21_27607980_27608165 | 0.58 |
ENSG00000206802 |
. |
45046 |
0.16 |
chr4_110223153_110224430 | 0.58 |
COL25A1 |
collagen, type XXV, alpha 1 |
8 |
0.99 |
chr13_76212170_76212445 | 0.57 |
LMO7 |
LIM domain 7 |
1848 |
0.28 |
chr17_58821066_58821723 | 0.57 |
ENSG00000252534 |
. |
5013 |
0.22 |
chr13_74637272_74637666 | 0.57 |
KLF12 |
Kruppel-like factor 12 |
68283 |
0.14 |
chr6_144008458_144008841 | 0.57 |
PHACTR2 |
phosphatase and actin regulator 2 |
9444 |
0.27 |
chr4_7937771_7938061 | 0.57 |
AC097381.1 |
|
2812 |
0.26 |
chr5_159510482_159510643 | 0.57 |
PWWP2A |
PWWP domain containing 2A |
35867 |
0.14 |
chr1_236308030_236308327 | 0.57 |
GPR137B |
G protein-coupled receptor 137B |
2110 |
0.37 |
chrX_139793107_139793258 | 0.57 |
LINC00632 |
long intergenic non-protein coding RNA 632 |
1250 |
0.53 |
chr6_166419889_166420278 | 0.57 |
ENSG00000252196 |
. |
64254 |
0.12 |
chr1_217263352_217263815 | 0.56 |
ESRRG |
estrogen-related receptor gamma |
607 |
0.86 |
chr9_20558698_20558876 | 0.56 |
ENSG00000252324 |
. |
17429 |
0.2 |
chr1_196576976_196577127 | 0.56 |
KCNT2 |
potassium channel, subfamily T, member 2 |
438 |
0.86 |
chr18_18697656_18697875 | 0.56 |
ENSG00000251886 |
. |
2702 |
0.29 |
chr2_66668625_66669005 | 0.56 |
AC092669.1 |
|
153 |
0.89 |
chr5_82577485_82577636 | 0.56 |
VCAN |
versican |
189724 |
0.03 |
chr3_181285218_181285513 | 0.56 |
SOX2-OT |
SOX2 overlapping transcript (non-protein coding) |
3856 |
0.36 |
chr8_72754626_72756069 | 0.56 |
RP11-383H13.1 |
Protein LOC100132891; cDNA FLJ53548 |
20 |
0.96 |
chr3_157154723_157155399 | 0.56 |
PTX3 |
pentraxin 3, long |
483 |
0.86 |
chr3_87030882_87031292 | 0.56 |
VGLL3 |
vestigial like 3 (Drosophila) |
8765 |
0.33 |
chr11_112848535_112848686 | 0.56 |
ENSG00000238998 |
. |
535 |
0.79 |
chr12_52257745_52258098 | 0.56 |
ANKRD33 |
ankyrin repeat domain 33 |
23823 |
0.16 |
chr3_77091074_77091225 | 0.56 |
ROBO2 |
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
1268 |
0.6 |
chr2_20648707_20648907 | 0.55 |
RHOB |
ras homolog family member B |
1972 |
0.34 |
chr2_3465758_3466116 | 0.55 |
TRAPPC12 |
trafficking protein particle complex 12 |
3507 |
0.21 |
chr4_151001634_151001785 | 0.55 |
DCLK2 |
doublecortin-like kinase 2 |
1529 |
0.55 |
chr7_120632386_120632537 | 0.55 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
2785 |
0.27 |
chr17_73126799_73128080 | 0.55 |
NT5C |
5', 3'-nucleotidase, cytosolic |
23 |
0.94 |
chr8_41200524_41200675 | 0.55 |
SFRP1 |
secreted frizzled-related protein 1 |
33583 |
0.15 |
chr3_112798260_112798787 | 0.55 |
ENSG00000238593 |
. |
12849 |
0.18 |
chr6_141884450_141884959 | 0.55 |
ENSG00000222764 |
. |
77155 |
0.13 |
chr9_80638102_80638399 | 0.55 |
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
7270 |
0.32 |
chr3_187930915_187931066 | 0.55 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
269 |
0.94 |
chr4_16897303_16897454 | 0.54 |
LDB2 |
LIM domain binding 2 |
2807 |
0.43 |
chr5_119782760_119782911 | 0.54 |
PRR16 |
proline rich 16 |
17138 |
0.29 |
chr21_39227684_39227918 | 0.54 |
KCNJ6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
57756 |
0.14 |
chr21_48080967_48081118 | 0.54 |
PRMT2 |
protein arginine methyltransferase 2 |
16787 |
0.23 |
chr5_39420318_39420469 | 0.54 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
4577 |
0.31 |
chr3_197829934_197830170 | 0.54 |
AC073135.3 |
|
7025 |
0.18 |
chr3_25470623_25470774 | 0.54 |
RARB |
retinoic acid receptor, beta |
896 |
0.71 |
chr6_132520617_132520826 | 0.53 |
ENSG00000265669 |
. |
84318 |
0.1 |
chr10_76349397_76349548 | 0.53 |
ENSG00000206756 |
. |
38322 |
0.19 |
chr4_163085121_163085733 | 0.53 |
FSTL5 |
follistatin-like 5 |
240 |
0.96 |
chr11_94528311_94528492 | 0.53 |
AMOTL1 |
angiomotin like 1 |
26864 |
0.2 |
chr17_63738678_63738916 | 0.53 |
CEP112 |
centrosomal protein 112kDa |
8045 |
0.32 |
chrX_39949292_39950247 | 0.53 |
BCOR |
BCL6 corepressor |
6887 |
0.33 |
chr1_200343235_200343386 | 0.53 |
ZNF281 |
zinc finger protein 281 |
35810 |
0.22 |
chr2_72684771_72684922 | 0.53 |
ENSG00000222536 |
. |
264089 |
0.02 |
chr7_120630679_120630951 | 0.53 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
1139 |
0.51 |
chr4_3323595_3323746 | 0.53 |
RGS12 |
regulator of G-protein signaling 12 |
5875 |
0.26 |
chr3_133020578_133020729 | 0.53 |
RP11-402L6.1 |
|
44621 |
0.17 |
chr5_77147504_77148481 | 0.53 |
TBCA |
tubulin folding cofactor A |
16612 |
0.28 |
chr1_164546141_164546408 | 0.53 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
14232 |
0.25 |
chr6_149368169_149368320 | 0.53 |
RP11-162J8.3 |
|
14535 |
0.25 |
chr1_32230049_32230559 | 0.53 |
BAI2 |
brain-specific angiogenesis inhibitor 2 |
190 |
0.92 |
chr9_137097669_137097820 | 0.52 |
ENSG00000221676 |
. |
68058 |
0.1 |
chr3_173460576_173460750 | 0.52 |
NLGN1 |
neuroligin 1 |
138274 |
0.05 |
chr10_89435565_89435716 | 0.52 |
PAPSS2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
14932 |
0.19 |
chr14_77491443_77491668 | 0.52 |
IRF2BPL |
interferon regulatory factor 2 binding protein-like |
3479 |
0.25 |
chr22_40845374_40845546 | 0.52 |
MKL1 |
megakaryoblastic leukemia (translocation) 1 |
13962 |
0.16 |
chr6_143508631_143508782 | 0.52 |
AIG1 |
androgen-induced 1 |
61319 |
0.13 |
chr21_17652021_17652264 | 0.52 |
ENSG00000201025 |
. |
4947 |
0.35 |
chr9_16704056_16704545 | 0.52 |
BNC2 |
basonuclin 2 |
780 |
0.71 |
chr13_45145551_45145847 | 0.52 |
TSC22D1 |
TSC22 domain family, member 1 |
4693 |
0.31 |
chr12_3308931_3310293 | 0.51 |
TSPAN9 |
tetraspanin 9 |
729 |
0.75 |
chr7_111079006_111079157 | 0.51 |
IMMP2L |
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
46110 |
0.2 |
chr5_124194835_124194993 | 0.51 |
ZNF608 |
zinc finger protein 608 |
110414 |
0.06 |
chr11_10690622_10690773 | 0.51 |
MRVI1 |
murine retrovirus integration site 1 homolog |
16774 |
0.18 |
chr19_9608666_9608918 | 0.51 |
ZNF560 |
zinc finger protein 560 |
491 |
0.79 |
chr1_201506374_201506568 | 0.51 |
CSRP1 |
cysteine and glycine-rich protein 1 |
27887 |
0.14 |
chr5_71453247_71453481 | 0.51 |
ENSG00000264099 |
. |
11930 |
0.23 |
chr5_53444022_53444173 | 0.51 |
ENSG00000265421 |
. |
72684 |
0.11 |
chr8_77317816_77317967 | 0.51 |
ENSG00000222231 |
. |
139924 |
0.05 |
chr11_83392322_83392502 | 0.51 |
DLG2 |
discs, large homolog 2 (Drosophila) |
637 |
0.8 |
chr6_139692606_139692757 | 0.51 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
2669 |
0.37 |
chr6_6752053_6752282 | 0.51 |
LY86-AS1 |
LY86 antisense RNA 1 |
129163 |
0.05 |
chr9_117658240_117658391 | 0.51 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
34382 |
0.2 |
chr15_66994787_66995642 | 0.51 |
SMAD6 |
SMAD family member 6 |
540 |
0.83 |
chr3_8561489_8561767 | 0.51 |
LMCD1 |
LIM and cysteine-rich domains 1 |
17241 |
0.2 |
chr11_111849006_111849202 | 0.51 |
DIXDC1 |
DIX domain containing 1 |
1071 |
0.39 |
chr2_217144138_217144289 | 0.51 |
AC012513.6 |
|
19895 |
0.17 |
chr1_186153285_186153546 | 0.51 |
GS1-174L6.4 |
|
6981 |
0.23 |
chr2_10122063_10122214 | 0.51 |
GRHL1 |
grainyhead-like 1 (Drosophila) |
13296 |
0.16 |
chr15_42749089_42749416 | 0.51 |
ZNF106 |
zinc finger protein 106 |
459 |
0.78 |
chr8_93284767_93284918 | 0.51 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
169328 |
0.04 |
chr3_185531595_185531973 | 0.50 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
7065 |
0.24 |
chr21_17960305_17960805 | 0.50 |
ENSG00000207863 |
. |
2002 |
0.4 |
chr6_22329035_22329186 | 0.50 |
PRL |
prolactin |
31380 |
0.23 |
chr5_167003606_167003757 | 0.50 |
CTB-78F1.1 |
|
83805 |
0.1 |
chr13_80705528_80705730 | 0.50 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
208165 |
0.03 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.7 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 0.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 0.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.8 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.6 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 1.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 0.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 1.2 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.2 | 0.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.2 | 0.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.3 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.2 | 0.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 1.1 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.2 | 0.3 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.2 | 0.5 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.7 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 1.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.6 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.3 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.5 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.6 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.4 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.3 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.3 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.3 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.6 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.2 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.4 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0072070 | loop of Henle development(GO:0072070) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.4 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.1 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.5 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0072189 | ureter development(GO:0072189) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.1 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 1.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.1 | 0.2 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.4 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.3 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.1 | GO:0010659 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 1.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:2000831 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.3 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.0 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.3 | GO:0035065 | regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) regulation of peptidyl-lysine acetylation(GO:2000756) |
0.0 | 0.1 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.2 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.4 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.6 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.6 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.2 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.0 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0032652 | regulation of interleukin-1 production(GO:0032652) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.3 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.8 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.3 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.1 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.0 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.2 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 1.5 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.0 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0090266 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.2 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.6 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.5 | GO:0014032 | neural crest cell development(GO:0014032) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.0 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.2 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.2 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.9 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.1 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.0 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.1 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.2 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.0 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.0 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.1 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.4 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.0 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 2.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.2 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.0 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.1 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.0 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.2 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.9 | GO:0007626 | locomotory behavior(GO:0007626) |
0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.0 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.0 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.0 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.3 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0045916 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.2 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.0 | 1.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.3 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.0 | GO:0021532 | neural tube patterning(GO:0021532) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.0 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 1.5 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.0 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.0 | 0.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.0 | 0.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 1.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 1.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.8 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.7 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.0 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 3.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 2.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.4 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.0 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 2.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.5 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.9 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 3.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.9 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.0 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.3 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.5 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 1.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.8 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 1.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.3 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.5 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 1.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.8 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.8 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 2.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 2.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.0 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.0 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.0 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.0 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.0 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 1.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 4.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 4.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 3.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 2.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.3 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 4.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |